7 Hills Pharma LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1995-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.7hillspharma.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Phase 1
Recruiting
- Conditions
- Pleural MesotheliomaRenal Cell CancerKidney CancerAnaplastic Lymphoma Kinase Genomic Tumor AberrationsALK Genomic Tumor AberrationsMelanomaAdvanced CancerMetastasisAdvanced Solid TumorSkin Cancer
- Interventions
- First Posted Date
- 2024-04-12
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- 7 Hills Pharma, LLC
- Target Recruit Count
- 126
- Registration Number
- NCT06362369
- Locations
- 🇺🇸
Florida Cancer Specialists, Lake Mary, Florida, United States
🇺🇸Dartmouth Hitchcock, Lebanon, New Hampshire, United States
🇺🇸MD Anderson Cancer Center, Houston, Texas, United States
A Phase 1 SAD and MAD Study of the Safety, Tolerability and PK of 7HP349 in Normal Healthy Male Subjects
Phase 1
Completed
- Conditions
- Solid Tumor
- Interventions
- Drug: 7HP349 Single Ascending DoseDrug: Placebo Single Ascending DoseDrug: Placebo Multiple Ascending DoseDrug: 7HP349 Multiple Ascending DoseDrug: 7HP349 Food Effect
- First Posted Date
- 2020-08-11
- Last Posted Date
- 2021-11-02
- Lead Sponsor
- 7 Hills Pharma, LLC
- Target Recruit Count
- 60
- Registration Number
- NCT04508179
- Locations
- 🇺🇸
Frontage Clinical Services Inc., Secaucus, New Jersey, United States
News
No news found